Matteo Benelli

9.1k total citations · 1 hit paper
81 papers, 3.2k citations indexed

About

Matteo Benelli is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Matteo Benelli has authored 81 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 33 papers in Molecular Biology and 33 papers in Cancer Research. Recurrent topics in Matteo Benelli's work include Cancer Genomics and Diagnostics (28 papers), Advanced Breast Cancer Therapies (23 papers) and Genomic variations and chromosomal abnormalities (10 papers). Matteo Benelli is often cited by papers focused on Cancer Genomics and Diagnostics (28 papers), Advanced Breast Cancer Therapies (23 papers) and Genomic variations and chromosomal abnormalities (10 papers). Matteo Benelli collaborates with scholars based in Italy, United States and United Kingdom. Matteo Benelli's co-authors include Francesca Demichelis, Alberto Magi, Francesca Torricelli, Olivier Elemento, Himisha Beltran, Scott T. Tagawa, Andrea Sboner, Juan Miguel Mosquera, David M. Nanus and Mark A. Rubin and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Matteo Benelli

76 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer

2016 1.1k citations Himisha Beltran, Juan Miguel Mosquera et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matteo Benelli Italy	26	1.6k	1.5k	1.1k	871	499	81	3.2k
Mustafa Özen United States	34	2.7k 1.7×	1.0k 0.7×	1.8k 1.6×	758 0.9×	410 0.8×	90	4.2k
Philip Jonsson United States	27	1.4k 0.9×	462 0.3×	902 0.8×	773 0.9×	485 1.0×	41	2.8k
Håkan Axelson Sweden	37	2.8k 1.7×	524 0.3×	1.4k 1.3×	885 1.0×	311 0.6×	90	4.1k
Rile Li United States	29	1.5k 0.9×	1.1k 0.7×	569 0.5×	854 1.0×	221 0.4×	37	3.0k
Tracy Stockley Canada	24	905 0.6×	523 0.3×	781 0.7×	549 0.6×	481 1.0×	136	2.5k
Erik J. Uhlmann United States	30	1.7k 1.1×	589 0.4×	447 0.4×	734 0.8×	317 0.6×	73	3.4k
Chloé B. Steen United States	17	1.7k 1.1×	828 0.5×	851 0.8×	1.2k 1.4×	158 0.3×	29	3.8k
Monica Cantile Italy	35	2.1k 1.3×	447 0.3×	1.2k 1.1×	962 1.1×	285 0.6×	133	3.5k
Fengju Chen United States	26	1.6k 1.0×	553 0.4×	703 0.6×	680 0.8×	176 0.4×	62	3.1k
Scott M. Welford United States	24	1.6k 1.0×	671 0.4×	1.2k 1.0×	418 0.5×	133 0.3×	60	2.6k

Countries citing papers authored by Matteo Benelli

Since Specialization

Citations

This map shows the geographic impact of Matteo Benelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matteo Benelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matteo Benelli more than expected).

Fields of papers citing papers by Matteo Benelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matteo Benelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matteo Benelli. The network helps show where Matteo Benelli may publish in the future.

Co-authorship network of co-authors of Matteo Benelli

This figure shows the co-authorship network connecting the top 25 collaborators of Matteo Benelli. A scholar is included among the top collaborators of Matteo Benelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matteo Benelli. Matteo Benelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Belmonte, Beatrice, Sheila Spada, Paola Allavena, et al.. (2025). Highlighting recent achievements to advance more effective cancer immunotherapy. Journal of Experimental & Clinical Cancer Research. 44(1). 57–57. 1 indexed citations

Galardi, Francesca, Massimo De Paoli, Dario Romagnoli, et al.. (2025). 52P Dynamics of ctDNA and serum thymidine kinase activity in patients with ER+/HER2- metastatic breast cancer receiving abemaciclib vs palbociclib or ribociclib: Early results of the TIRESIAS trial. ESMO Open. 10. 104606–104606.

Migliaccio, Ilenia, Dario Romagnoli, Francesca Galardi, et al.. (2024). Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial. JCO Precision Oncology. 8(8). e2300285–e2300285. 4 indexed citations

Romagnoli, Dario, Agostina Nardone, Francesca Galardi, et al.. (2023). MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samples. Briefings in Bioinformatics. 24(2). 1 indexed citations

Migliaccio, Ilenia, Emanuela Risi, Chiara Biagioni, et al.. (2022). PIK3CA co-occurring mutations and copy-number gain in hormone receptor positive and HER2 negative breast cancer. npj Breast Cancer. 8(1). 24–24. 10 indexed citations

Risi, Emanuela, C. Lisanti, Alessia Vignoli, et al.. (2022). Risk assessment of disease recurrence in early breast cancer: A serum metabolomic study focused on elderly patients. Translational Oncology. 27. 101585–101585. 2 indexed citations

Benelli, Matteo, Gian Marco Franceschini, Alberto Magi, et al.. (2021). Charting differentially methylated regions in cancer with Rocker-meth. Communications Biology. 4(1). 1249–1249. 8 indexed citations

Migliaccio, Ilenia, Angela Leo, Francesca Galardi, et al.. (2021). Circulating Biomarkers of CDK4/6 Inhibitors Response in Hormone Receptor Positive and HER2 Negative Breast Cancer. Cancers. 13(11). 2640–2640. 8 indexed citations

Vignoli, Alessia, Elena Mori, Samantha Di Donato, et al.. (2021). Exploring Serum NMR-Based Metabolomic Fingerprint of Colorectal Cancer Patients: Effects of Surgery and Possible Associations with Cancer Relapse. Applied Sciences. 11(23). 11120–11120. 3 indexed citations

10.

Galardi, Francesca, Francesca De Luca, Chiara Biagioni, et al.. (2021). Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial. Breast Cancer Research. 23(1). 38–38. 25 indexed citations

11.

McCartney, Amelia, Martina Bonechi, Francesca De Luca, et al.. (2020). Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd Trial. Clinical Cancer Research. 26(9). 2131–2139. 37 indexed citations

12.

Ghini, Veronica, Letizia Laera, Francesca Del Monte, et al.. (2020). Metabolomics to Assess Response to Immune Checkpoint Inhibitors in Patients with Non-Small-Cell Lung Cancer. Cancers. 12(12). 3574–3574. 74 indexed citations

13.

Migliaccio, Ilenia, Martina Bonechi, Amelia McCartney, et al.. (2020). CDK4/6 inhibitors: A focus on biomarkers of response and post-treatment therapeutic strategies in hormone receptor-positive HER2-negative breast cancer. Cancer Treatment Reviews. 93. 102136–102136. 21 indexed citations

14.

Wu, Anjui, Paolo Cremaschi, Daniel Wetterskog, et al.. (2020). Genome-wide plasma DNA methylation features of metastatic prostate cancer. Journal of Clinical Investigation. 130(4). 1991–2000. 64 indexed citations

15.

Benelli, Matteo, Andrea Barucci, Nicola Zoppetti, et al.. (2020). Comprehensive Analysis of Radiomic Datasets by RadAR. Cancer Research. 80(15). 3170–3174. 6 indexed citations

16.

Beltran, Himisha, Alessandro Romanel, Vincenza Conteduca, et al.. (2020). Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer. Journal of Clinical Investigation. 130(4). 1653–1668. 132 indexed citations

17.

Romagnoli, Dario, Giulia Boccalini, Martina Bonechi, et al.. (2018). ddSeeker: a tool for processing Bio-Rad ddSEQ single cell RNA-seq data. BMC Genomics. 19(1). 960–960. 16 indexed citations

18.

Benelli, Matteo, Dario Romagnoli, & Francesca Demichelis. (2018). Tumor purity quantification by clonal DNA methylation signatures. Bioinformatics. 34(10). 1642–1649. 30 indexed citations

19.

McNair, Christopher, Kexin Xu, Amy C. Mandigo, et al.. (2017). Differential impact of RB status on E2F1 reprogramming in human cancer. Journal of Clinical Investigation. 128(1). 341–358. 70 indexed citations

20.

Gourain, Victor, Markus Reischl, Pierre Affaticati, et al.. (2016). A novel brain tumour model in zebrafish reveals the role of YAP activation in MAPK/PI3K induced malignant growth. Disease Models & Mechanisms. 10(1). 15–28. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact